Synapse - David Scheinberg

Results (18)

Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker

Journal Article

Dacek, M. M.; Kurtz, K. G.; Wallisch, P.; Pierre, S. A.; Khayat, S.; Bourne, C. M.; Gardner, T. J.; Vogt, K. C.; Aquino, N.; Younes, A.; more...
Blood (2023)

Fulltext@MSK | Save

Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma

Journal Article

Mondello, P.; Tadros, S.; Teater, M.; Fontan, L.; Chang, A. Y.; Jain, N.; Yang, H.; Singh, S.; Ying, H. Y.; Chu, C. S.; more...
Cancer Discovery (2020)

Fulltext@MSK | Save

Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations

Journal Article

Mondello, P.; Brea, E. J.; De Stanchina, E.; Toska, E.; Chang, A. Y.; Fennell, M.; Seshan, V.; Garippa, R.; Scheinberg, D. A.; Baselga, J.; more...
JCI Insight (2017)

Fulltext@MSK | Save

Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma

Journal Article

Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V.; Hendrickson, R. C.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
Oncotarget (2017)

Fulltext@MSK | Save

Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma

Meeting Abstract

Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
Blood (2016)

Fulltext@MSK | Save

Multivalent DNA aptamer-based therapeutic agents for lymphoma and leukemia

Meeting Abstract

Mallikaratchy, P.; Ruggiero, A.; Maguire, W.; Piersanti, K.; Gardner, J.; Villa, C.; Escorcia, F.; Palomba, M. L.; Heaney, M.; McDevitt, M. R.; more...
Blood (2009)

Fulltext@MSK | Save

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses

Journal Article

Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia

Journal Article

Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma

Journal Article

Palomba, M. L.; Roberts, W. K.; Dao, T.; Manukian, G.; Guevara-Patiño, J. A.; Wolchok, J. D.; Scheinberg, D. A.; Houghton, A. N.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Xenogeneic DNA immunization against CD20 elicits immune responses and confers modest tumor protection in a mouse model of lymphoma

Meeting Abstract

Palomba, M. L.; Roberts, W. K.; Scheinberg, D. A.; Houghton, A. N.
Blood (2002)

Fulltext@MSK | Save